HHS OIG Identifies Opportunities to Strengthen NIH Grantees’ Oversight of Investigators’ Foreign Financial Interests Read more
FDA Releases Draft Guidance on IND Submissions for Individualized Antisense Oligonucleotide Drug Products Read more